Łukasz Galus

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Topics

Fluorescent Probe

Saccharomyces Cerevisiae

Prognostic Factors

Top Venues

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Natalia Szóstak, Luiza Handschuh, Anna Samelak-Czajka, Katarzyna Tomela, Bernadeta Pietrzak, Marcin Schmidt, Łukasz Galus, Jacek Mackiewicz, Andrzej Adam Mackiewicz, Kozłowski Piotr, Anna Philips
Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti-PD-1 Therapy. Cancer immunology research 12 (4) (2024)
Natalia Szóstak, Luiza Handschuh, Anna Samelak-Czajka, Katarzyna Tomela, Bernadeta Pietrzak, Marcin Schmidt, Łukasz Galus, Jacek Mackiewicz, Andrzej Adam Mackiewicz, Kozłowski Piotr, Anna Philips
Gut mycobiota dysbiosis is associated with melanoma and response to anti-PD-1 therapy. Cancer immunology research (2024)
Natalia Szóstak, Luiza Handschuh, Anna Samelak-Czajka, Katarzyna Tomela, Bernadeta Pietrzak, Marcin Schmidt, Łukasz Galus, Jacek Mackiewicz, Andrzej Adam Mackiewicz, Kozłowski Piotr, Anna Philips
Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti-PD-1 Therapy. Cancer immunology research 12 (4) (2024)
Katarzyna Tomela, Bernadeta Pietrzak, Łukasz Galus, Jacek Mackiewicz, Marcin Schmidt, Andrzej Adam Mackiewicz, Mariusz Kaczmarek
Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy. Cells 12 (5) (2023)
Katarzyna Tomela, Bernadeta Pietrzak, Łukasz Galus, Jacek Mackiewicz, Marcin Schmidt, Andrzej Adam Mackiewicz, Mariusz Kaczmarek
Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy. Cells 12 (5) (2023)
Łukasz Galus, Michał Michalak, Mateusz Lorenz, Renata Stoińska-Swiniarek, Daria Tusień Małecka, Agnieszka Galus, Tomasz Kolenda, Ewa Leporowska, Jacek Mackiewicz
Vitamin D supplementation increases objective response rate and prolongs progression-free time in patients with advanced melanoma undergoing anti-PD1 therapy. Cancer (2023)
Paula Kamińska, Karolina Buszka, Łukasz Galus, Maurycy Jankowski, Michal Nowicki, Jacek Mackiewicz, Mariusz Kaczmarek, Joanna Budna-Tukan
Circulating Melanoma Cell Numbers Correlate with TIGIT-Positive Cytotoxic T Cell Counts in Advanced-Stage Melanoma Patients. Cells 12 (6) (2023)
Katarzyna Tomela, Bernadeta Pietrzak, Łukasz Galus, Jacek Mackiewicz, Marcin Schmidt, Andrzej Adam Mackiewicz, Mariusz Kaczmarek
Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy. Cells 12 (5) (2023)
Łukasz Galus, Michał Michalak, Mateusz Lorenz, Renata Stoińska-Swiniarek, Daria Tusień Małecka, Agnieszka Galus, Tomasz Kolenda, Ewa Leporowska, Jacek Mackiewicz
Vitamin D supplementation increases objective response rate and prolongs progression-free time in patients with advanced melanoma undergoing anti-PD1 therapy. Cancer (2023)
Paula Kamińska, Karolina Buszka, Łukasz Galus, Maurycy Jankowski, Michal Nowicki, Jacek Mackiewicz, Mariusz Kaczmarek, Joanna Budna-Tukan
Circulating Melanoma Cell Numbers Correlate with TIGIT-Positive Cytotoxic T Cell Counts in Advanced-Stage Melanoma Patients. Cells 12 (6) (2023)
Katarzyna Tomela, Bernadeta Pietrzak, Łukasz Galus, Jacek Mackiewicz, Marcin Schmidt, Andrzej Adam Mackiewicz, Mariusz Kaczmarek
Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy. Cells 12 (5) (2023)
Łukasz Galus, Michał Michalak, Mateusz Lorenz, Renata Stoińska-Swiniarek, Daria Tusień Małecka, Agnieszka Galus, Tomasz Kolenda, Ewa Leporowska, Jacek Mackiewicz
Vitamin D supplementation increases objective response rate and prolongs progression-free time in patients with advanced melanoma undergoing anti-PD1 therapy. Cancer (2023)
Joanna Placzke, Magdalena Rosinska, Paweł Sobczuk, Marcin Ziętek, Natasza Kempa-Kamińska, Bozena Cybulska-Stopa, Grażyna Kamińska-Winciorek, Wiesław Bal, Jacek Mackiewicz, Łukasz Galus, Manuela Las-Jankowska, Michał Jankowski, Robert Dziura, Kamil Drucis, Aneta Borkowska, Tomasz Świtaj, Paweł Rogala, Katarzyna Kozak, Anna Klimczak, Paulina Jagodzińska-Mucha, Anna Szumera-Ciećkiewicz, Hanna Kosela-Paterczyk, Piotr Rutkowski
Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report. Cancers 15 (17) (2023)
Paula Kamińska, Karolina Buszka, Łukasz Galus, Maurycy Jankowski, Michal Nowicki, Jacek Mackiewicz, Mariusz Kaczmarek, Joanna Budna-Tukan
Circulating Melanoma Cell Numbers Correlate with TIGIT-Positive Cytotoxic T Cell Counts in Advanced-Stage Melanoma Patients. Cells 12 (6) (2023)
Bernadeta Pietrzak, Katarzyna Tomela, Agnieszka Olejnik-Schmidt, Łukasz Galus, Jacek Mackiewicz, Mariusz Kaczmarek, Andrzej Adam Mackiewicz, Marcin Schmidt
A Clinical Outcome of the Anti-PD-1 Therapy of Melanoma in Polish Patients Is Mediated by Population-Specific Gut Microbiome Composition. Cancers 14 (21) (2022)
Bozena Cybulska-Stopa, Renata Pacholczak-Madej, Grażyna Kamińska-Winciorek, Marcin Ziętek, Anna Małgorzata Czarnecka, Karolina Piejko, Łukasz Galus, Barbara Ziółkowska, Stanisław Kieszko, Natasza Kempa-Kamińska, Jacek Calik, Janusz Rolski, Agata Sałek-Zań, Katarzyna Gajewska-Wicher, Anna Drosik-Kwaśniewska, Paweł Rogala, Tomasz Kubiatowski, Rafał Suwinski, Jacek Mackiewicz, Piotr Lukasz Rutkowski
First-line treatment of advanced/metastatic melanoma with anti-PD-1 antibodies: multicenter experience in Poland. Immunotherapy 13 (4) (2020)